Skip to main content Accessibility help
×
Home

Switching to amisulpride due to hepatic complications

  • Oktay Yagdiran (a1), Christian Haasen (a1), Evangelia Nika (a1), Michael Krausz (a1) and Dieter Naber (a1)...

Abstract

  • An abstract is not available for this content so a preview has been provided below. Please use the Get access link above for information on how to access this content.

Copyright

Corresponding author

*Corresponding author. Tel.: +49-40-42803-3241; fax: -49-40-42803-9135 E-mail address: yagdiran@uke.uni-hamburg.de (O. Yagdiran).

References

Hide All
1Beasley, CMTollefson, GDTran, PVSafety of olanzapine. J. Clin. Psychiatry 1997;58(Suppl. 10):13–7.
2Coulouvrat, CDondey-Nouvel, LSafety of amisulpride (Soliant): a review of 11 clinical studies. Int. Clin. Psychophar-macol. 1999;14:209–18.
3Dorta, GSiebenmann, RFrohli, PKoelz, HRClozapin-induzierter cholestatischer Ikterus: Ein Fallbericht. Z. Gastro-entrol. 1989;27:388–90.
4Gupta, SMansand, PSOlanzapine: review of its pharmacology and indications in clinical practice. Prim. Psychiatry 1997;4: 73–82.
5Hummer, MKurz, MKurzthaler, IOberbauer, HMiller, CFleischhacker, WWHepatotoxicity of clozapine. J. Clin. Pharmacol. 1997;17:314–7.
6Lammert, FMatern, SHepatopathien durch Medikamente. Schweiz Rundsch Med. Prax. 1997;86:1167–71.
7McEvoy, JPScheifler, PLFrances, AThe expert consensus guideline series: treatment of schizophrenia. J. Clin. Psychiatry 1999;60(Suppl. 11):3–80.
8Naber, DLambert, MKrausz, MHaasen, CAtypical Antipsychotics in the Treatment of Schizophrenic Patients. Bremen: Uni-Med; 2001.
9Selim, KKaplowitz, NHepatotoxicity of psychotropic drugs. Hepatology 1999;29:1347–51.

Keywords

Switching to amisulpride due to hepatic complications

  • Oktay Yagdiran (a1), Christian Haasen (a1), Evangelia Nika (a1), Michael Krausz (a1) and Dieter Naber (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Switching to amisulpride due to hepatic complications

  • Oktay Yagdiran (a1), Christian Haasen (a1), Evangelia Nika (a1), Michael Krausz (a1) and Dieter Naber (a1)...
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *